About N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide
N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide (PubChem CID 165162283) has the molecular formula C27H32N6O4
and a molecular weight of 504.59 g/mol. Its IUPAC name is N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide.
Molecular Properties
| Compound Name | N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide |
| PubChem CID | 165162283 |
| Molecular Formula | C27H32N6O4 |
| Molecular Weight | 504.59 g/mol |
| Exact Mass | 504.25 |
| IUPAC Name | N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide |
| SMILES | Cc1cccc(C(=O)Nc2cc3cn(C4CCC(C)(O)CC4)nc3cc2-n2ccc(C(C)(C)O)n2)[n+]1[O-] |
| InChI | InChI=1S/C27H32N6O4/c1-17-6-5-7-22(33(17)37)25(34)28-21-14-18-16-32(19-8-11-27(4,36)12-9-19)29-20(18)15-23(21)31-13-10-24(30-31)26(2,3)35/h5-7,10,13-16,19,35-36H,8-9,11-12H2,1-4H3,(H,28,34) |
| InChIKey | MZJRJIQHNAKVRG-UHFFFAOYSA-N |
| XLogP | 3.51 |
| TPSA | 132.14 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 504.59 |
| LogP ≤ 5 | 3.51 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Analyze N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide?
The IUPAC name of N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide (CID 165162283) is N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide.
What is the SMILES notation for N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide?
The canonical SMILES for N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide is Cc1cccc(C(=O)Nc2cc3cn(C4CCC(C)(O)CC4)nc3cc2-n2ccc(C(C)(C)O)n2)[n+]1[O-].
What is the InChIKey of N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide?
The InChIKey is MZJRJIQHNAKVRG-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H32N6O4/c1-17-6-5-7-22(33(17)37)25(34)28-21-14-18-16-32(19-8-11-27(4,36)12-9-19)29-20(18)15-23(21)31-13-10-24(30-31)26(2,3)35/h5-7,10,13-16,19,35-36H,8-9,11-12H2,1-4H3,(H,28,34).
What are the key properties of N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide?
N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide has a molecular weight of 504.59 g/mol, XLogP of 3.51, 5 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-hydroxy-4-methylcyclohexyl)-6-[3-(2-hydroxypropan-2-yl)pyrazol-1-yl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide is sourced from PubChem (CID 165162283), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).